These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 18693152)

  • 1. Thiopurine S-methyltransferase genotypic analysis in autoimmune bullous diseases.
    Bezier M; Reguiai Z; Vitry F; Broly F; Bernard P
    Eur J Dermatol; 2008; 18(5):512-7. PubMed ID: 18693152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An audit of thiopurine methyltransferase genotyping and phenotyping before intended azathioprine treatment for dermatological conditions.
    Vestergaard T; Bygum A
    Clin Exp Dermatol; 2010 Mar; 35(2):140-4. PubMed ID: 19663853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of thiopurine methyltransferase genotyping and phenotyping, and measurement of azathioprine metabolites in the management of patients with autoimmune hepatitis.
    Heneghan MA; Allan ML; Bornstein JD; Muir AJ; Tendler DA
    J Hepatol; 2006 Oct; 45(4):584-91. PubMed ID: 16876902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of thiopurine methyltransferase enzyme activity is superior to genotype in predicting myelosuppression following azathioprine therapy in patients with inflammatory bowel disease.
    Winter JW; Gaffney D; Shapiro D; Spooner RJ; Marinaki AM; Sanderson JD; Mills PR
    Aliment Pharmacol Ther; 2007 May; 25(9):1069-77. PubMed ID: 17439508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thiopurine methyltransferase (TPMT) activity and adverse effects of azathioprine in inflammatory bowel disease: long-term follow-up study of 394 patients.
    Gisbert JP; Niño P; Rodrigo L; Cara C; Guijarro LG
    Am J Gastroenterol; 2006 Dec; 101(12):2769-76. PubMed ID: 17026564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of genetic variation in thiopurine methyltransferase activity and the efficacy and/or side effects of azathioprine therapy in dermatologic patients.
    Snow JL; Gibson LE
    Arch Dermatol; 1995 Feb; 131(2):193-7. PubMed ID: 7857117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of thiopurine methyltransferase activity in the safety and efficacy of azathioprine in the treatment of pemphigus vulgaris.
    Firooz A; Ghandi N; Hallaji Z; Chams-Davatchi C; Valikhani M; Karbakhsh Davari M
    Arch Dermatol; 2008 Sep; 144(9):1143-7. PubMed ID: 18794458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thiopurine methyltransferase gene polymorphisms in Chinese patients with inflammatory bowel disease.
    Cao Q; Zhu Q; Shang Y; Gao M; Si J
    Digestion; 2009; 79(1):58-63. PubMed ID: 19252404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced thiopurine methyltransferase activity and development of side effects of azathioprine treatment in patients with rheumatoid arthritis.
    Stolk JN; Boerbooms AM; de Abreu RA; de Koning DG; van Beusekom HJ; Muller WH; van de Putte LB
    Arthritis Rheum; 1998 Oct; 41(10):1858-66. PubMed ID: 9778228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Association between metabolic enzyme genotype of azathioprine and drug tolerance in patients with rheumatic diseases].
    Zhan ZP; Liang LQ; Yang XY; Wang YX; Huang M; Li H
    Zhonghua Yi Xue Za Zhi; 2007 Jul; 87(25):1734-7. PubMed ID: 17919375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening for azathioprine toxicity: a pharmacoeconomic analysis based on a target case.
    Tavadia SM; Mydlarski PR; Reis MD; Mittmann N; Pinkerton PH; Shear N; Sauder DN
    J Am Acad Dermatol; 2000 Apr; 42(4):628-32. PubMed ID: 10727309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TPMT genotype and its clinical implication in renal transplant recipients with azathioprine treatment.
    Song DK; Zhao J; Zhang LR
    J Clin Pharm Ther; 2006 Dec; 31(6):627-35. PubMed ID: 17176368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Normal thiopurine methyltransferase phenotype testing in a Crohn disease patient with azathioprine induced myelosuppression.
    Leung M; Piatkov I; Rochester C; Boyages SC; Leong RW
    Intern Med J; 2009 Feb; 39(2):121-6. PubMed ID: 19356188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thiopurine dose in intermediate and normal metabolizers of thiopurine methyltransferase may differ three-fold.
    Gardiner SJ; Gearry RB; Begg EJ; Zhang M; Barclay ML
    Clin Gastroenterol Hepatol; 2008 Jun; 6(6):654-60; quiz 604. PubMed ID: 18467186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monitoring of thiopurine methyltransferase activity in postsurgical patients with Crohn's disease during 1 year of treatment with azathioprine or mesalazine.
    Dilger K; Schaeffeler E; Lukas M; Strauch U; Herfarth H; Müller R; Schwab M
    Ther Drug Monit; 2007 Feb; 29(1):1-5. PubMed ID: 17304143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Choice of azathioprine or 6-mercaptopurine dose based on thiopurine methyltransferase (TPMT) activity to avoid myelosuppression. A prospective study.
    Gisbert JP; Luna M; Maté J; González-Guijarro L; Cara C; Pajares JM
    Hepatogastroenterology; 2006; 53(69):399-404. PubMed ID: 16795981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic polymorphism of thiopurine S-methyltransferase in Argentina.
    Laróvere LE; de Kremer RD; Lambooy LH; De Abreu RA
    Ann Clin Biochem; 2003 Jul; 40(Pt 4):388-93. PubMed ID: 12880540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of thiopurine S-methyltransferase polymorphism in the population of Serbia and Montenegro and mercaptopurine therapy tolerance in childhood acute lymphoblastic leukemia.
    Dokmanovic L; Urosevic J; Janic D; Jovanovic N; Petrucev B; Tosic N; Pavlovic S
    Ther Drug Monit; 2006 Dec; 28(6):800-6. PubMed ID: 17164697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of thiopurine methyltransferase activity and 6-thioguanine nucleotide concentrations in patients with chronic inflammatory diseases.
    Schedel J; Gödde A; Schütz E; Bongartz TA; Lang B; Schölmerich J; Müller-Ladner U
    Ann N Y Acad Sci; 2006 Jun; 1069():477-91. PubMed ID: 16855176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacogenetics of thiopurine therapy in paediatric IBD patients.
    De Ridder L; Van Dieren JM; Van Deventer HJ; Stokkers PC; Van der Woude JC; Van Vuuren AJ; Benninga MA; Escher JC; Hommes DW
    Aliment Pharmacol Ther; 2006 Apr; 23(8):1137-41. PubMed ID: 16611274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.